Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
KIMS •NSE
Krishna Institute of Medical Sciences
₹809.8518.00 (2.27%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events
Performance
Today’s low
784.00
Today’s high
819.00
52 week low
575.80
52 week high
858.00
Open price
793.40
Previous close
791.85
Live volume
12,42,321
Lower circuit
633.50
Upper circuit
950.20
Fundamentals
Market Cap
₹33,241Cr
ROE
10.74%
P/E Ratio(TTM)
170.94
EPS(TTM)
4.63
P/B Ratio
8.87
Dividend Yield
0.00%
Industry P/E
66.97
Book Value
89.22
Debt to Equity
1.89
Face Value
2
Financial performance
JUN '26
₹1,196Cr
+10.29%
₹37.40Cr
+12.99%
03006009001.2k
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +36% |
| 3Y CAGR | +21% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -56% |
| 3Y CAGR | -13% |
About
Krishna Institute of Medical Sciences Limited (KIMS Hospitals) operates a chain of multi-specialty hospitals in India.;
CEO/MD
Bhaskara Rao Bollineni
Founded in
1973
NSE symbol
KIMS
Shareholding pattern
Mutual Funds Invested (4)
Similar stocks
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Fortis HealthcareFORTIS | ₹886.00 -0.10 (0.01%) | 66,983.66 | 62.57 | 6.77 | ||
Aster DM Quality CareASTERDM | ₹755.05 -5.60 (0.74%) | 66,281.97 | 182.79 | 15.76 | ||
Global HealthMEDANTA | ₹1,499.40 +75.40 (5.29%) | 38,261.80 | 69.28 | 9.66 | ||
₹1,928.50 +59.90 (3.21%) | 38,239.99 | 46.83 | 8.43 |
Livesquawk •
KIMS denies reports of $52M stake acquisition talks with Renova Hospitals.
The company stated no agreements or discussions have occurred.
Livesquawk •
KIMS issues 77,02,182 warrants to promoters for Rs. 150 crore funding.
The funding is part of a planned capital raise by Krishna Institute of Medical Sciences.
Livesquawk •
KIMS plans to allocate future cash flows to greenfield expansion over debt repayment.
The company targets a debt-to-equity ratio of approximately 2.5:1, per concall update.
Livesquawk •
KIMS anticipates improved Q2 performance over Q1, driven by new hospital momentum.
Seasonal variations in case mix are expected but won't hinder growth, per concall update.
Livesquawk •
KIMS confirms 4%-5% ARPOB growth guidance, rejecting higher 6%-7% as too aggressive.
Livesquawk •
KIMS projects Kondapur Hospital to generate ₹1,200 Cr annual revenue in 4-5 years.
Management shared this update during the latest concall session.
2026
3
Aug
Quarterly Result
Release date
15
May
Quarterly & Annual Result
Release date
6
Feb
Quarterly Result
Release date
2025
7
Nov
Quarterly Result
Release date
6
Aug
Quarterly Result
Release date
Events calendar
View upcoming events in other stocks